The public remains in the dark about how many of the clinical trials it paid for panned out, according to research in the Lancet that blames lack of government enforcement.

The Federal Trade Commission can proceed with its antitrust suit against health information company Surescripts LLC after a federal judge dismissed the company’s attempts to reject the government’s case.

Amgen filed patent-infringement lawsuits against Torrent and Zydus Cadila, claiming their proposed generic versions of Corlanor infringe four patents for the heart-disease treatment.

The owner of a California hospital got a 15-month prison sentence for his role in a long-running scheme in which he paid over $30 million in kickbacks to doctors who steered patients to his facility, the Department of Justice said.

The U.S. Supreme Court agreed to hear the Trump administration’s bid to give employers and universities the broad right to claim a religious or moral exemption from the Obamacare requirement that they offer free birth control through their health-care plans.

Boston Scientific Corp. said it will ask Delaware’s top court to overturn a ruling ordering it to complete its $275 million acquisition of Channel MedSystems Inc. despite Channel’s submission of false data to drug regulators.